Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Page Options
E-Mail This Search
Clinical Trial Questions?
Get Help:
1-800-4-CANCER
or
LiveHelp online chat
Quick Links
Help Using the NCI Clinical Trials Search Form
Educational Materials About Clinical Trials
About NCI's Cancer Clinical Trials Registry
Dictionary of Cancer Terms
NCI Drug Dictionary
View Content for:
Patients
Health Professionals
Display:
Title
Description with:
Locations
Eligibility
Full Trial Description
Custom
Results 1-9 of 9 for your search:
Drug:
dronabinol
Find trials that include:
Any drugs shown
Trial Status:
Closed
Hide Search Criteria
Show Search Criteria
Help with Results
Select All on Page
Sort by:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Show
10
25
50
100
200
Results per Page
1.
Phase III Compazine vs Methadone vs Tetrahydrocannabinol vs Placebo in Patients Receiving ADR for Malignant Neoplasms
Phase:
Phase III, Phase II
Type:
Supportive care
Status:
Completed
Age:
no age specified
Sponsor:
Protocol IDs:
MAYO-818304
, NCCTG-818304, NCI-W82-1092, W82-1092
2.
Phase III Randomized, Double-Blind Study of Megestrol vs Dronabinol vs Both in Patients with Cancer-Related Anorexia and Cachexia
Phase:
Phase III
Type:
Supportive care
Status:
Closed
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
NCCTG-959255
, NCI-P96-0075
3.
Phase III Antiemetic Therapy with Intramuscular Levonantradol vs Oral Tetrahydrocannabinol for Patients Receiving Antineoplastic Chemotherapy
Phase:
Phase III
Type:
Supportive care
Status:
Closed
Age:
18 and over
Sponsor:
Protocol IDs:
UMCC-8135
4.
Randomized Double-Blind Comparison of Metoclopramide vs Tetrahydrocannabinol to Control CACP-Induced Vomiting
Phase:
Phase II, Phase I
Type:
Supportive care
Status:
Closed
Age:
18 and over
Sponsor:
Protocol IDs:
MSKCC-8127
5.
Phase II Oral vs Rectal Tetrahydrocannabinol in the Treatment of CACP-Induced Nausea and Vomiting
Phase:
Phase II
Type:
Supportive care
Status:
Closed
Age:
no age specified
Sponsor:
Protocol IDs:
NCI-D81-043-517
, MDA-PC-8101
6.
Randomized Double-Blind Comparison of Tetrahydrocannabinol vs Haloperidol as Antiemetics for Cancer Patients Receiving Chemotherapy
Phase:
No phase specified
Type:
Supportive care
Status:
Closed
Age:
16 and over
Sponsor:
Protocol IDs:
NCI-D79-035-229
, OSU-79HO156
7.
Effect of Dosage Level on Antiemetic Properties of Tetrahydrocannabinol in Cancer Patients with Chemotherapy-Induced Nausea and Vomiting
Phase:
No phase specified
Type:
Supportive care
Status:
Closed
Age:
over 18
Sponsor:
Protocol IDs:
NCI-D81-014-437
8.
Antiemetic Therapy with THC for Patients Undergoing Chemotherapy for Cancer
Phase:
No phase specified
Type:
Supportive care
Status:
Closed
Age:
21 to 65
Sponsor:
Protocol IDs:
UMCC-7903
9.
Randomized Comparison of Droperidol vs Tetrahydrocannabinol as Anti-Emetics in Patients with Gynecologic Malignancies Treated with CACP
Phase:
No phase specified
Type:
Supportive care
Status:
Completed
Age:
no age specified
Sponsor:
NCI
Protocol IDs:
GOG-51
Select All on Page
Help with Results
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute